Citius Pharmaceuticals Inc banner

Citius Pharmaceuticals Inc
NASDAQ:CTXR

Watchlist Manager
Citius Pharmaceuticals Inc Logo
Citius Pharmaceuticals Inc
NASDAQ:CTXR
Watchlist
Price: 0.7291 USD 0.84% Market Closed
Market Cap: $15.1m

Bankruptcy Probability

Citius Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .

We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.

Bankruptcy Probability
HIDDEN
Show

Financial Position

Cash & ST Investments
+
3Y
-79%
5Y
+80%
10Y
+2 474%
Long-Term Investments
+
3Y
-
5Y
-
10Y
-
Debt
+
3Y
-
5Y
+150%
10Y
-

Solvency Ratios

Solvency Ratios Comparison
Citius Pharmaceuticals Inc Competitors

Country Company Market Cap D/E D/A Interest
Coverage
Altman
Z-Score
Quick
Ratio
Current
Ratio
Cash
Ratio
US
Citius Pharmaceuticals Inc
NASDAQ:CTXR
16.2m USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
289.1B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
246.1B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.1B GBP
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found
Is Citius Pharmaceuticals Inc at risk of bankruptcy?

Citius Pharmaceuticals Inc's probability of bankruptcy is hidden .

The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Citius Pharmaceuticals Inc have?

As of the latest report, Citius Pharmaceuticals Inc has total debt of 1m USD. This includes both short-term (1m USD) and long-term (0 USD) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett